Favorable outcomes of NPM1 AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance.
作者信息
Khan I, Kaempf A, Raghuwanshi S, Chesnokov M, Zhang X, Wang Z, Domling A, Tyner J W, Camacho C, Gartel A L
机构信息
University of Illinois at Chicago, Department of Medicine, Chicago, IL, USA.
Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
出版信息
Blood Cancer J. 2023 Aug 22;13(1):128. doi: 10.1038/s41408-023-00898-4.
Abstract
摘要
Zotero 插件